NO995657L - Kombinasjonsterapi for endring av human seksuell respons - Google Patents

Kombinasjonsterapi for endring av human seksuell respons

Info

Publication number
NO995657L
NO995657L NO995657A NO995657A NO995657L NO 995657 L NO995657 L NO 995657L NO 995657 A NO995657 A NO 995657A NO 995657 A NO995657 A NO 995657A NO 995657 L NO995657 L NO 995657L
Authority
NO
Norway
Prior art keywords
combination therapy
sexual response
human sexual
changing human
changing
Prior art date
Application number
NO995657A
Other languages
English (en)
Other versions
NO322079B1 (no
NO995657D0 (no
Inventor
Joseph S Podolski
Original Assignee
Zonagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zonagen Inc filed Critical Zonagen Inc
Publication of NO995657D0 publication Critical patent/NO995657D0/no
Publication of NO995657L publication Critical patent/NO995657L/no
Publication of NO322079B1 publication Critical patent/NO322079B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO19995657A 1997-05-19 1999-11-18 Blanding som omfatter en alfa-adrenerg antagonist og en dopaminerg agonist. NO322079B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4994797P 1997-05-19 1997-05-19
PCT/US1998/010230 WO1998052569A1 (en) 1997-05-19 1998-05-19 Combination therapy for modulating the human sexual response

Publications (3)

Publication Number Publication Date
NO995657D0 NO995657D0 (no) 1999-11-18
NO995657L true NO995657L (no) 2000-01-18
NO322079B1 NO322079B1 (no) 2006-08-14

Family

ID=21962609

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995657A NO322079B1 (no) 1997-05-19 1999-11-18 Blanding som omfatter en alfa-adrenerg antagonist og en dopaminerg agonist.

Country Status (17)

Country Link
EP (1) EP0996447B1 (no)
JP (2) JP4588809B2 (no)
KR (1) KR20010012721A (no)
CN (1) CN1262622A (no)
AT (1) ATE333279T1 (no)
AU (1) AU749703B2 (no)
BR (1) BR9809848A (no)
CA (1) CA2291160C (no)
DE (1) DE69835288T2 (no)
DK (1) DK0996447T3 (no)
ES (1) ES2270517T3 (no)
HK (1) HK1028197A1 (no)
IL (2) IL132853A0 (no)
NO (1) NO322079B1 (no)
NZ (1) NZ500921A (no)
PT (1) PT996447E (no)
WO (1) WO1998052569A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
US6011043A (en) * 1998-06-19 2000-01-04 Schering Corporation Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
DE19834507A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil
US6482426B1 (en) * 1998-09-17 2002-11-19 Zonagen, Inc. Compositions for the treatment of male erectile dysfunction
CA2251255A1 (en) * 1998-10-20 2000-04-20 Mcgill University The use of dopaminergic agents in the management of sexual dysfunction
US6087362A (en) * 1999-03-16 2000-07-11 Pentech Pharmaceuticals, Inc. Apomorphine and sildenafil composition
AU4203600A (en) * 1999-04-06 2000-10-23 Zonagen, Inc. Methods for modulating the human sexual response
WO2001008659A1 (en) * 1999-07-30 2001-02-08 Lakefield Minerals Ltd. Pharmaceutical compositions for topical application to treat erectile dysfunction
KR100344198B1 (ko) * 1999-10-08 2002-07-19 일양약품주식회사 실데나필 시트레이트의 속효제형
TWI265925B (en) 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
KR20020020536A (ko) * 2000-09-09 2002-03-15 장우영 발기유발제
WO2009152344A2 (en) * 2008-06-11 2009-12-17 Comgenrx, Inc. Combination therapy using phosphodiesterase inhibitors
US7678078B1 (en) 2008-10-21 2010-03-16 KMG Pharma LLC Intravitreal injection device, system and method
GB201221032D0 (en) * 2012-11-22 2013-01-09 Mens Health Ltd Method of treatment

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742054A (en) * 1982-11-23 1988-05-03 Naftchi Nosrat E Treatment of mammals suffering from damage to the central nervous system
ZA878182B (en) * 1986-11-05 1988-05-02 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
FR2649613B1 (fr) * 1989-07-11 1991-09-27 Virag Ronald Medicament vaso-actif
FR2680106B1 (fr) * 1991-08-09 1994-03-11 Corbiere Gerome Procede de realisation de formes pharmaceutiques stables d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
DK0758895T3 (da) * 1994-04-22 2000-06-13 Pentech Pharmaceuticals Inc Sublinguale dosisformer indeholdende apomorphin til anvendelse ved behandling af erektil dysfunktion
CN1113757A (zh) * 1994-06-24 1995-12-27 王儒新 一种性功能促进剂及其制备方法
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
JPH09110674A (ja) * 1995-10-16 1997-04-28 Kao Corp 浴用剤組成物

Also Published As

Publication number Publication date
JP2009280621A (ja) 2009-12-03
DK0996447T3 (da) 2006-11-13
PT996447E (pt) 2006-12-29
CN1262622A (zh) 2000-08-09
DE69835288T2 (de) 2007-07-19
IL132853A (en) 2010-04-15
NO322079B1 (no) 2006-08-14
ES2270517T3 (es) 2007-04-01
EP0996447B1 (en) 2006-07-19
NZ500921A (en) 2002-11-26
AU749703B2 (en) 2002-07-04
CA2291160C (en) 2008-10-28
ATE333279T1 (de) 2006-08-15
AU7498098A (en) 1998-12-11
IL132853A0 (en) 2001-03-19
NO995657D0 (no) 1999-11-18
KR20010012721A (ko) 2001-02-26
WO1998052569A1 (en) 1998-11-26
EP0996447A1 (en) 2000-05-03
JP2001526686A (ja) 2001-12-18
CA2291160A1 (en) 1998-11-26
HK1028197A1 (en) 2001-02-09
BR9809848A (pt) 2000-06-27
JP4588809B2 (ja) 2010-12-01
DE69835288D1 (de) 2006-08-31

Similar Documents

Publication Publication Date Title
NO995657L (no) Kombinasjonsterapi for endring av human seksuell respons
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
EA200200208A1 (ru) Синергитическая композиция
ES2191152T3 (es) Terapia combinada para el tratamiento de psicosis.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
EP1254899A3 (en) Piperazine derivatives and their use as anti-inflammatory agents
ATE376832T1 (de) Verzögert freisetzende formulierungen von oxymorphon
ATE254456T1 (de) Cannabinoid-rezeptor-antagonisten
DE69926806D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
TR199701105T1 (xx) �midazo (1,2-a)piridin t�revleri.
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
HK1029922A1 (en) Angiostatic agents and compositions for treating glc1a glaucoma
ATE332903T1 (de) Kondensierte pyridoindolderivate
ATE203519T1 (de) Chinolinderivate als antimalariamittel
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
NO980296L (no) Forbedrede terapeutiske midler
HUP0002836A2 (hu) Makrociklusos bisz(3,3'-indolil)-maleinimid-származékok alkalmazása bőrrendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására
NO20001548L (no) Endotelinantagonist og en renin-angiotensinsystem inhibitor som et kombinert preparat
EA200601592A1 (ru) Фармацевтическая композиция, содержащая ингибитор pde4 или pde3/4 и антагонист гистаминового рецептора
ATE337320T1 (de) Indolderivate als pde5-inhibitoren
NO20005548L (no) Mykobakterieinhibitorer
DE69827017D1 (de) Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
ID24922A (id) Terapi kombinasi untuk pengobatan aids
CY1106922T1 (el) Ενωσεις ισοκινολινυλ αροϋλ πυρρολης για την αγωγη των διαταραχων κεντρικου νευρικου συστηματος

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees